Samare-NajafM, KouchakiH, Moein MahiniS, et al.Prostate cancer: Novel genetic and immunologic biomarkers. Clin Chim Acta, 2024; 555:117824; doi: 10.1016/j.cca.2024.117824
2.
GaleyL, OlanrewajuA, NabiH, et al.PSA, an outdated biomarker for prostate cancer: In search of a more specific biomarker, citrate takes the spotlight. J Steroid Biochem Mol Biol, 2024; 243:106588; doi: 10.1016/j.jsbmb.2024.106588
3.
DjamgozMBA, FraserSP, BrackenburyWJ. In vivo evidence for voltage-gated sodium channel expression in carcinomas and potentiation of metastasis. Cancers (Basel), 2019; 11(11):1675; doi: 10.3390/cancers11111675
4.
DjamgozMBA. Electrical excitability of cancer cells-CELEX model updated. Cancer Metastasis Rev, 2024; 43(4):1579–1591; doi: 10.1007/s10555-024-10195-6
5.
LaniadoME, LalaniEN, FraserSP, et al.Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol, 1997; 150(4):1213–1221.
6.
DissJK, ArcherSN, HiranoJ, et al.Expression profiles of voltage-gated Na(+) channel alpha-subunit genes in rat and human prostate cancer cell lines. Prostate, 2001; 48(3):165–178; doi: 10.1002/pros.1095
7.
DissJK, StewartD, PaniF, et al.A potential novel marker for human prostate cancer: Voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis, 2005; 8(3):266–273; doi: 10.1038/sj.pcan.4500796
8.
HouseCD, VaskeCJ, SchwartzAM, et al.Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res, 2010; 70(17):6957–6967; doi: 10.1158/0008-5472.CAN-10-1169
9.
GradekF, Lopez-CharcasO, ChadetS, et al.Sodium channel Nav1.5 controls epithelial-to-mesenchymal transition and invasiveness in breast cancer cells through its regulation by the salt-inducible kinase-1. Sci Rep, 2019; 9;9(1):18652; doi: 10.1038/s41598-019-55197-5
10.
BarrettT, RiemerF, McLeanMA, et al.Quantification of total and intracellular sodium concentration in primary prostate cancer and adjacent normal prostate tissue with magnetic resonance imaging. Invest Radiol, 2018; 53(8):450–456; doi: 10.1097/RLI.0000000000000470
11.
YildirimS, AltunS, GumushanH, et al.Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo. Cancer Lett, 2012; 323(1):58–61; doi: 10.1016/j.canlet.2012.03.036
12.
BuganI, KucukS, KaragozZ, et al.Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate. Prostate Cancer Prostatic Dis, 2019; 22(4):569–579; doi: 10.1038/s41391-019-0128-3
13.
DingY, BrackenburyWJ, OnganerPU, et al.Epidermal growth factor upregulates motility of Mat-LyLu rat prostate cancer cells partially via voltage-gated Na+ channel activity. J Cell Physiol, 2008; 215(1):77–81; doi: 10.1002/jcp.21289
14.
DjamgozMBA. Ranolazine: A potential anti-metastatic drug targeting voltage-gated sodium channels. Br J Cancer, 2024; 130(9):1415–1419; doi: 10.1038/s41416-024-02622-w
15.
DjamgozMBA. Combinatorial therapy of cancer: Possible advantages of involving modulators of ionic mechanisms. Cancers (Basel), 2022; 14(11):2703; doi: 10.3390/cancers14112703
